Spyre (NASDAQ: SYRE) legal chief trims stake in planned share sale What happened Spyre Therapeutics...
Topics
Spyre (NASDAQ: SYRE) legal chief trims stake in planned share sale What happened Spyre Therapeutics, Inc. (NASDAQ: SYRE) Chief Legal Officer and Corporate Secretary Heidy King-Jones sold 28,933 shares on 2026-10-01. The Form 4 shows five sale blocks at weighted-average prices from $89.24 to $93.46 per share, totaling about $2.63 million. It also shows a separate 28,933-share option exercise at $14.5 per share, and the filing
Related QATS news
- Better High-Yield Dividend Stock: Pfizer or Novo Nordisk? Novo Nordisk is a leading GLP-1 company, ...
- Kodiak AI Targets Year-End Driverless Dallas-Houston Trucking Launch With IKEA Kodiak AI NASDAQ: KD...
- Forget the S&P 500: SCHD Is Beating It by Nearly 10 Points in 2026 and Its Dividend Just Grew SCHD ...
- Is Netflix (NFLX) Stock a Buy? Netflix is huge and still growing. But its valuation isn't dirt chea...